The State of the Union: The Science and Legality of Psychedelics in Texas (Austin) May2026

Curious about the evolving landscape of psychedelic research and policy in Texas? Join us for a panel discussion during this significant turning point: the state’s decision to launch its own $50 million clinical trial program for ibogaine. Texas leadership announced that state-funded research will now proceed through statewide medical institutions after private sector proposals did not meet the specific criteria set by the Legislature. This move marks a historic shift in the state’s approach to medical research, placing Texas at the forefront of evaluating new interventions for treatment-resistant conditions and opioid addiction.

This discussion will feature a deep dive into the practical challenges and long-term implications of a state government managing its own clinical trials and the critical role of leaders in psychedelic advocacy. Our expert panelists will examine the logistical hurdles of state-led drug development, the complexities of navigating federal regulatory frameworks like the FDA and how this initiative could serve as a new model for medical research.

Why attend? Whether you are a healthcare professional, a policy analyst, or a resident interested in the future of medical research, this event provides an inside look at the shifting legal and scientific tides. In addition to the ibogaine developments, we will provide updates on the current status of psychedelic-related research in Texas, and how Texas legislation has impacted legislation in Tennessee and New Mexico. You will leave with a fresh perspective on how regional policy is shaping the national conversation on psychedelic therapies, so you can be a skillful advocate in the Psychedelic Renaissance.

Join us for an insightful and inspiring discussion on the future of psychedelic research and policy!

Bio of Speaker/Panelists:

Logan Davidson is the founding Executive Director, Senior Advisor and Policy Director of Texans for Greater Mental Health, supporting psychedelic therapies in Texas. Before joining T4GMH, he was a legislative and political staffer with bipartisan experience at the state and federal level. He served as Legislative Director and Chief of Staff for Representative Alex Dominguez, where he shepherded Texas' historic psychedelic therapy law, HB 1802, to passage and implementation. Logan graduated from Texas Tech University, received his MBA from the University of North Texas, and he resides in Austin, Texas.

Braden Hand is the Legislative Director for Americans for Ibogaine whose mission is to advance public understanding and responsible medical access to ibogaine. He has nearly a decade of experience at the highest levels of Texas state government as a policy professional. Having served in the offices of the Texas Governor and the Speaker of the Texas House, Braden offers an insider’s perspective on the legislative process and the administrative considerations behind major state-funded medical initiatives.

Dr. Manoj Doss, Ph.D., studies the basic neurocognitive mechanisms of psychoactive drugs, with a particular focus on the impact of psychedelics on different learning and memory processes in humans. Doss received a bachelor’s from The University of Texas at Austin, a master’s from University College London, postbaccalaureate training from University of California, Davis, a doctorate from the University of Chicago and postdoctoral training at the Center for Psychedelic and Consciousness Research at Johns Hopkins University School of Medicine before returning to UT.

PsyT Disclaimer: Version Jan2026

PsyT does not host ceremonies or promote illegal activities. We provide a platform to discuss experiences that offer transformation in our personal and professional lives. This is not a space to seek, share, promote, or procure controlled substances, retreats, or related services. Please do not contact us for these purposes or share images of prohibited substances, even for identification. All information provided by PsyT is for educational purposes and is not a substitute for medical advice, diagnosis, or treatment. The views expressed by presenters are their own and do not necessarily reflect those of our community. We are committed to maintaining a safe, respectful, and inclusive environment. Harassment, unsafe behavior, or unfounded claims about individuals are not tolerated in any PsyT space, online or in person.